What is Conceive?
Founded in 2021, Conceive operates as a specialized digital fertility and health platform provider. The company distinguishes itself by integrating clinical-grade health insights with user-centric digital tools, effectively bridging the gap between medical expertise and patient accessibility. In an industry characterized by high fragmentation, Conceive has carved out a distinct market position by focusing on data-driven outcomes and personalized care pathways. The platform serves as a critical interface for users seeking to manage reproductive health, providing a comprehensive suite of services that align with the broader shift toward digital-first healthcare delivery models. By prioritizing user experience and clinical efficacy, the company has established itself as a notable player in the burgeoning fertility technology space.
How much funding has Conceive raised?
Conceive has raised a total of $3.7M across 1 funding round:
Angel/Seed
$3.7M
Angel/Seed (2022): $3.7M with participation from Great Oaks, Kindred Ventures, and Founder Collective
Key Investors in Conceive
Great Oaks
Great Oaks is a career and technical education institution that provides specialized training and educational resources for students and professionals.
Kindred Ventures
Kindred Ventures is a venture capital firm that provides strategic backing to early-stage technology companies with high growth potential.
Founder Collective
Founder Collective is a venture capital fund focused on seed and pre-seed investments, partnering with exceptional entrepreneurs from the idea stage to IPO.
What's next for Conceive?
With the recent capital deployment, Conceive is expected to prioritize the scaling of its enterprise-facing solutions, likely targeting partnerships with large-scale employers looking to enhance their reproductive health benefits. The strategic roadmap suggests a focus on deepening the platform's analytical capabilities and potentially integrating more robust telehealth features to support its growing user base. As the company moves beyond its initial development phase, the focus will shift toward sustainable growth and market penetration, ensuring that its digital fertility solutions remain at the forefront of the healthtech sector. Investors will be monitoring the company's ability to maintain its high-touch service model while scaling its technological infrastructure to meet the demands of a broader, more diverse demographic.
See full Conceive company page
